Pharmakon Advisors Extends $125MM Credit Facility with Evolus
Evolus, a performance beauty company, extended the expiration date of the second undrawn tranche under its existing term loan financing facility with investment funds managed by Pharmakon Advisors to Dec. 31, 2023.
December 9, 2022
David Moatazedi | Evolus | Pedro Gonzalez de Cosio | Pharmakon Advisors
Ian Koplin